Title : Genetic variations in the PI3K/AKT pathway predict platinum-based neoadjuvant chemotherapeutic sensitivity in squamous cervical cancer.

Pub. Date : 2015 Dec 15

PMID : 26585822






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Genetic variations in the PI3K/AKT pathway predict platinum-based neoadjuvant chemotherapeutic sensitivity in squamous cervical cancer. Platinum AKT serine/threonine kinase 1 Homo sapiens
2 The PI3K/Akt pathway plays a role in chemoresistance to platinum-based neoadjuvant chemotherapy (NAC). Platinum AKT serine/threonine kinase 1 Homo sapiens
3 The objective of this study was to evaluate the association between genetic polymorphisms in the PI3K/Akt pathway and chemotherapeutic outcomes following platinum-based NAC in Northwestern Chinese Han patients with squamous cervical cancer (SCC). Platinum AKT serine/threonine kinase 1 Homo sapiens
4 SIGNIFICANCE: The findings from this study demonstrate that genetic polymorphisms in the PI3K/Akt pathway are associated with sensitivity to platinum-based chemotherapy in SCC patients. Platinum AKT serine/threonine kinase 1 Homo sapiens